Celgene and GlobeImmune form a Cancer Partnership
Taskin Ahmed
Abstract
GlobeImmune and Celgene Corporation agreed on a strategic alliance that will develop drugs that stimulate the immune system against cancer using GlobeImmune’s Tarmogen® technology.
Add comment

This work is licensed under a Creative Commons Attribution 3.0 License.